Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATORVASTATIN CALCIUM, with a corresponding US DMF Number 26571.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 08, 2013, and payment made on November 07, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II